Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Chemistry Analyzer for Small to Midsize Labs Does Precision Sampling

By LabMedica International staff writers
Posted on 23 Jul 2009
An advanced chemistry analyzer system optimizes workflow and enhances productivity in clinical laboratories. More...


Building on the success of its predecessor, the AU400e, the new AU480 minimizes sample volume requirements and features new intuitive GUI and master curve calibration. The AU480 is the ideal main analyzer for small to medium-sized laboratories due to its throughput of up to 800 tests per hour with ISE, and is simultaneously programmable for 63 different analytes. It can also be used as a special chemistry or STAT analyzer in large laboratories.

High-precision sampling, as little as 1 µl, makes the AU480 system ideal for neonatal, pediatric, and geriatric testing. Computer-controlled sample and reagent dispensing, in combination with clot detection and crash prevention, are added safety features of the AU480, resulting in unique system reliability.

The AU480 system accommodates up to 80 samples in racks and 22 in the STAT wheel. Different tube sizes may be mixed within the linear racks and loaded continuously. Serum indices (hemolysis, icterus, lipemia) can also be automatically checked.

Olympus Diagnostic Systems (Center Valley, PA, USA) diagnostic systems reagents for the AU480 are designed to match the requirements and features of the analyzer for optimum performance. Master curve reagents have 2-Dimension (2D) barcodes to maximize productivity and reduce the potential for errors in the laboratory.

The Olympus AU480 is standardized to fit seamlessly within the full line of Olympus AU-Series chemistry analyzers. All offer the same reagents, calibrators, controls, consumables, and parts; the same results and reference ranges; and the same test menu.

Olympus Diagnostic Systems provides solutions that meet the high productivity demands of hospitals, integrated healthcare delivery networks, reference labs, blood banks, physicians' office labs, veterinary labs, and pharmaceutical labs.

Related Links:

Olympus Diagnostic Systems




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Automated Urinalysis Solution
UN-9000
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

Secondary prevention after myocardial infarction or stroke relies on antiplatelet therapy, yet responses vary widely and both recurrent thrombosis and bleeding remain persistent risks. In the United Kingdom,... Read more

Molecular Diagnostics

view channel
Image: Signatera uses ctDNA analysis to identify residual tumor-derived genetic material after definitive treatment (image credit: Adobe Stock)

Blood-Based MRD Test Predicts Recurrence Risk After Lung Cancer Surgery

Assessing recurrence risk after surgery for early-stage non-small cell lung cancer remains challenging, complicating adjuvant therapy and surveillance decisions. Blood-based molecular residual disease... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

Type 1 diabetes (T1D) affects more than 9 million people worldwide, including 1.8 million children and adolescents, and often begins years before symptoms appear. Early identification of children who are... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.